Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Infinity Pharmaceuticals Inc patents

Recent patent applications related to Infinity Pharmaceuticals Inc. Infinity Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Infinity Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Infinity Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Infinity Pharmaceuticals Inc-related inventors




Date Infinity Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
05/18/17Heterocyclic compounds and uses thereof
05/04/17Tetrazolones as inhibitors of fatty acid synthase
03/30/17Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
02/02/17Transfer hydrogenation of cyclopamine analogs
01/26/17Cyclopamine analogs
08/25/16Heterocyclic compounds and uses thereof
08/04/16Heterocyclic compounds and uses thereof
07/21/16Heterocyclic compounds and uses thereof
06/23/16Enzymatic transamination of cyclopamine analogs
06/16/16Isolation of cyclopamine
06/09/16Methods of use of cyclopamine analogs
06/02/16Processes for preparing isoquinolinones and solid forms of isoquinolinones
05/05/16Heterocyclic compounds and uses thereof
04/28/16Treatment of cancers using pi3 kinase isoform modulators
01/28/16Treatment of rheumatoid arthritis and asthma using pi3 kinase inhibitors
01/28/16Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
01/21/16Chemical compounds, compositions and methods for kinase modulation
12/24/15Inhibitors of fatty acid amide hydrolase
12/03/15Inhibitors of fatty acid amide hydrolase, methods of treatment and methods of preparing same
11/12/15Combination therapies
11/12/15Combination therapies
10/15/15Heterocyclic compounds and uses thereof
10/08/15Treatment of cancers using pi3 kinase isoform modulators
09/03/15Heterocyclic compounds and uses thereof
08/27/15Fatty acid amide hydrolase inhibitors
08/13/15Heterocyclic compounds and uses thereof
05/07/15Heterocyclic compounds and uses thereof
04/23/15Heterocyclic compounds and uses thereof
04/16/15Heterocyclic compounds and uses thereof
04/09/15Isoxazolines as inhibitors of fatty acid amide hydrolase
01/29/15Heterocyclic compounds and uses thereof
01/22/15Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
12/25/14Treatment of cancers using pi3 kinase isoform modulators
12/18/14Cyclopamine analogs
12/18/14Processes for preparing isoquinolinones and solid forms of isoquinolinones
12/04/14Methods for stereoselective reduction
09/18/14Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
05/01/14Treatment of rheumatoid arthritis and asthma using pi3 kinase inhibitors
05/01/14Treatment of cancers using pi3 kinase isoform modulators
05/01/14Inhibitors of fatty acid amide hydrolase
04/17/14Methods of use of cyclopamine analogs
04/10/14Heterocyclic compounds and uses thereof
03/27/14Chemical compounds, compositions and methods for kinase modulation
03/20/14Tetrazolones as inhibitors of fatty acid synthase
12/26/13Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors
12/26/13Inhibitors of fatty acid amide hydrolase
12/19/13Inhibitors of fatty acid amide hydrolase
10/10/13Heterocyclic compounds and uses thereof
09/19/13Triazoles as inhibitors of fatty acid synthase
05/23/13Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
03/07/13Inhibitors of fatty acid amide hydrolase
02/28/13Heterocyclic compounds and uses thereof
01/31/13Heterocyclic compounds and uses thereof
01/31/13Heterocyclic compounds and uses thereof
05/10/12Anti-fatty acid amide hydrolase-2 antibodies and uses thereof
05/03/12Methods of treating liposarcoma
04/05/12Enzymatic transamination of cyclopamine analogs
03/15/12Transfer hydrogenation of cyclopamine analogs
03/15/12Transfer hydrogenation of cyclopamine analogs
03/08/12Analogs of benzoquinone-containing ansamycins and methods of use thereof
07/28/11Treatment of fibrotic conditions using hedgehog inhibitors
05/19/11Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
02/10/11Isoxazolines as inhibitors of fatty acid amide hydrolase
02/03/11Isoxazolines as inhibitors of fatty acid amide hydrolase
02/03/11Isoxazolines as inhibitors of fatty acid amide hydrolase
Patent Packs
07/29/10Compounds and methods for inhibiting the interaction of bcl proteins with binding partners







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Infinity Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Infinity Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';